The Stanford StartX-backed healthcare administration platform developer raised series C financing that took its overall funding to $160m.
Luma Health, a US-based patient communication software developer that counts Stanford-StartX Fund, among its investors, has received $130m in series C funding.
The round was led by growth equity firm FTV Capital and included unnamed existing investors. It increased the company’s overall funding to $160m.
Luma offers a mobile platform that allows healthcare providers to centralise and automate scheduling and communication with patients. The app helps patients find healthcare services and book and manage their medical appointments, and it is currently used by more than 550 health systems, hospitals, health centres and clinics across the US.
The company raised $16m in an August 2019 round led by growth equity firm PeakSpan Capital that included InHealth Ventures, a venture capital affiliate of medical diagnostics provider InHealth Group, as well as healthcare provider Texas Medical Center, networking equipment manufacturer Cisco unit Cisco Investments and VC firm US Venture Partners (USVP).
Luma had previously secured $6.3m in a 2018 series A round led by USVP with backing from Stanford-StartX Fund and unnamed existing investors.
Adnan Iqbal, co-founder and chief executive of Luma Health, said: “With this investment, we will continue to meet the demands of leading healthcare delivery systems nationwide and deliver on our promise to our customers: helping transform the complexities of healthcare into convenient, seamless experiences for their patients.”
– A version of this article first appeared on our sister site, Global Corporate Venturing.
